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OBJECTIVES The purpose of this study was to evaluate the relationship between the circadian blood
pressure (BP) rhythm and endothelial function in patients with essential hypertension.
BACKGROUND Hypertension is associated with alterations in resistance artery endothelial function. Patients
with a non-dipper circadian pattern of BP have a greater risk of cerebrovascular and
cardiovascular complications than do patients with a dipper circadian pattern.
METHODS We evaluated the forearm blood flow (FBF) response to inra-arterial acetylcholine (ACh), an
endothelium-dependent vasodilator, and isosorbide dinitrate (ISDN), an endothelium-
independent vasodilator, infusion in 20 patients with non-dipper hypertension and 20 age-
and gender-matched patients with dipper hypertension. The FBF was measured using a
mercury-filled Silastic strain-gauge plethysmograph.
RESULTS The 24-h systolic BP, as well as nocturnal systolic and diastolic BPs were higher in
non-dipper patients than in dipper patients. The 24-h urinary excretion of nitrite/nitrate and
cyclic guanosine monophosphate was lower in non-dippers than in dippers. The response of
FBF to ACh was smaller in non-dippers than in dippers (25.1  3.1 vs. 20.2  3.0
ml/min/100 ml tissue, p  0.05). The FBF response to ISDN was similar in dippers and
non-dippers. The FBF response to ACh was similar in the two groups following intra-arterial
infusion of the nitric oxide (NO) synthase inhibitor NG-monomethyl-L-arginine.
CONCLUSIONS These findings suggest that endothelium-dependent vasodilation is blunted through a
decrease in NO release in non-dippers compared with patients who have dipper
hypertension. (J Am Coll Cardiol 2002;40:2039–43) © 2002 by the American College of
Cardiology Foundation
Hypertension is associated with altered endothelial nitric
oxide (NO) release. Several lines of evidence have shown
that endothelium-dependent vasodilation evoked by NO
release in brachial (1–3), coronary (4), renal (5), and small
arteries (6) is impaired in patients with essential hyperten-
sion, which is a risk factor for cardiovascular and cerebro-
vascular disease. It has been postulated that endothelial
dysfunction is the initial step in the pathogenesis of athero-
sclerosis and plays an important role in maintaining hyper-
tension.
Studies have shown that 24-h ambulatory blood pressure
monitoring (ABPM) is a better predictor of subsequent
complications than spot measurements of blood pressure
(BP) (7,8). In addition, individuals with a non-dipper
circadian pattern of BP, in which the nocturnal decline in
BP is diminished or absent, are at increased risk for
cerebrovascular and cardiovascular complications than are
individuals with a dipper circadian rhythm (9,10). However,
little is known about the relationship between the circadian
rhythm of BP, especially nocturnal BP, and endothelial
function in patients with essential hypertension. We hy-
pothesized that patients with the non-dipper pattern would
have greater impairment of endothelial function than would
patients with the dipper pattern.
To evaluate endothelial function in patients with dipper
and non-dipper patterns of hypertension, we compared the
endothelium-dependent vasodilation induced by intra-
arterial acetylcholine (ACh) and endothelium-independent
vasodilation induced by isosorbide dinitrate (ISDN) infu-
sions in the presence and absence of the NO synthase
inhibitor NG-monomethyl-L-arginine (L-NMMA) in dip-
pers and non-dippers.
METHODS
Subjects. One hundred eight inpatients with essential hy-
pertension who were identified by office BP measurements
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underwent 24-h ABPM. From among patients demonstrat-
ing circadian BP variation, 20 non-dippers (13 men and 7
women; mean age 52.6 9.7 years) and 20 dippers (13 men
and 7 women; mean age 50.4  8.9 years) matched for age,
gender, body mass index, lipid profile, glucose metabolism,
and smoking habit were enrolled in this study. Spot BP
measurements were obtained in the Outpatient Clinic of
Hiroshima University Faculty of Medicine. Hypertension
was defined as an untreated systolic BP 140 mm Hg
and/or a BP 90 mm Hg in the sitting position on at least
three different occasions. Patients with secondary forms of
hypertension were excluded by appropriate clinical and
biochemical examinations. None of the patients had a
history of cardiovascular or cerebrovascular disease, hyper-
cholesterolemia, diabetes mellitus, liver disease, or renal
disease. The study protocol was approved by the Ethics
Committee of the Hiroshima University Faculty of Medi-
cine. Informed consent for participation was obtained from
all subjects.
24-h ABPM. Antihypertensive agents were withheld for at
least two weeks prior to data collection, and subjects were
placed on a regular diet that contained 170 mmol/day of
NaCl one week prior to data collection to allow the systemic
sodium balance and BP to stabilize. The dietary content of
potassium (100 mmol/day) and calcium (40 mmol/day) was
kept constant throughout the study. The caloric intake was
40 cal/kg daily. Meals were prepared in the Hiroshima
University Hospital kitchen. Rigid compliance to the diet
was confirmed by measuring the 24-h urinary excretion of
sodium, chloride, and potassium throughout the study. The
ABPM was performed from day 6 to day 7 of the dietary
period using a TM2420 (AND Co., Tokyo, Japan) device,
a noninvasive ambulatory BP monitor that was attached to
the upper left arm. The BP was measured based on
Korotkoff sounds during stepwise deflations (3.0  1.0 mm
Hg/step) of the cuff. The within-run precision of BP and
heart rate measurements were 4.0 mm Hg and 5.0%,
respectively. The reliability of this device had been previ-
ously confirmed (11). Both BP and heart rate measurements
were obtained at 30-min intervals. A non-dipper pattern
was defined as a difference in the mean BP of less than 10%
between the daytime (6:00 AM to 9:00 PM) and nighttime
hours (9:00 PM to 6:00 AM). Patients were confined to their
ward during the study and were maintained on a regular
schedule; they were awakened at approximately 6:00 AM,
and the room light was turned off at 9:00 PM. The 24-h
urinary excretions of norepinephrine (NE), nitrite/nitrate
(NOx), and cyclic guanosine monophosphate (cGMP) were
determined during ABPM.
Endothelial function. Forearm vascular responses to ACh
(Daiichi Pharmaceutical, Tokyo, Japan) and ISDN (Eisai
Pharmaceutical, Tokyo, Japan) were evaluated from day 7 of
dietary period after disattachment of ABPM device in all
subjects. The study began at 8:30 AM. Subjects fasted the
previous night for at least 12 h. They were kept in the
supine position in a quiet, dark, air-conditioned room
(temperature 22°C to 25°C) throughout the study. A 23-
gauge polyethylene catheter (Hakkow, Okayama, Japan)
was inserted into the left brachial artery for the infusion of
ACh and ISDN and for the recording of arterial pressure
with an AP-641G pressure transducer (Nihon Kohden,
Tokyo, Japan) under local anesthesia (1% lidocaine). An-
other catheter was inserted into the left deep antecubital
vein to obtain blood samples.
After the patients were placed for 30 min in the supine
position, we measured forearm blood flow (FBF) and
arterial BP. Then, the effects of the ACh and ISDN on
forearm hemodynamics were measured. Both ACh (7.5, 15,
and 30 g/min) and ISDN (0.75, 1.5, and 3.0 g/min)
were infused intra-arterially for 5 min at each dose using a
constant rate infusion pump (Terfusion STG-523, Termo,
Tokyo, Japan). The FBF was measured during the last 2
min of the infusion. The infusions of ACh and ISDN were
carried out in a random order. Each study proceeded after
the FBF had returned to baseline.
Furthermore, after a 30-min rest period, an NO synthase
inhibitor, L-NMMA, was infused intra-arterially at a dose
of 8 mol/min for 5 min while the basal FBF and arterial
BP were recorded, and ACh (7.5, 15, and 30 g/min) was
administered.
Measurement of FBF. The FBF was measured using a
mercury-filled Silastic strain-gauge plethysmograph (EC-
5R, D.E. Hokanson, Bellevue, Washington) as previously
described (2,3). Forearm vascular resistance was calculated
as the mean arterial pressure divided by FBF. The FBF was
calculated by two independent observers blinded to the
study protocol from the linear portions of plethysmographic
recordings. The intraobserver coefficient of variation was 3.0
 2.1%. We confirmed the reproducibility of FBF re-
sponses to ACh and ISDN on two separate occasions in 10
healthy male subjects (mean age 24  4 years). The
coefficients of variation were 6.2  3.8% and 4.6  2.9%,
respectively.
Analytical methods. Routine chemical methods were used
to determine serum concentrations of total cholesterol,
creatinine, glucose and electrolytes, and urinary electrolytes.
Plasma renin activity and plasma concentration of angio-
tensin II were assayed by radioimmunoassay. Plasma and
urinary concentrations of NE were measured by high-
Abbreviations and Acronyms
ABPM  ambulatory blood pressure monitoring
ACh  acetylcholine
ANOVA  analysis of variance
BP  blood pressure
FBF  forearm blood flow
ISDN  isosorbide dinitrate
L-NMMA  NG-monomethyl-L-arginine
NE  norepinephrine
NO  nitric oxide
NOx  nitrite/nitrate
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performance liquid chromatography. Plasma and urinary
concentrations of cGMP were measured by radioimmuno-
assay using a cGMP kit (Yamasa Shoyu, Choshi, Japan).
Plasma and urinary concentrations of NOx were assayed by
colorimetric methods using NOx assay kits (Cayman
Chemical, Ann Arbor, Michigan).
Statistical analysis. Results are presented as the mean 
SD. Values of p  0.05 were considered statistically
significant. Comparisons of variables were carried out by the
one-way analysis of variance (ANOVA) followed by the
Bonferroni correction. Comparisons of time-course curves
of parameters during the infusions of ACh and ISDN were
analyzed by two-way ANOVA for repeated measures on
one factor followed by the Bonferroni correction for
multiple-paired comparisons. The data were processed us-
ing the software packages StatView IV (SAS Institute,
Cary, North Carolina) or Super ANOVA (Abacus Con-
cepts, Berkeley, California).
RESULTS
Clinical characteristics of dippers and nondippers. The
baseline clinical characteristics of the 20 patients with the
dipper pattern and the 20 patients with the non-dipper
pattern are summarized in Table 1. Both the 24-h systolic
BP and the nocturnal systolic and diastolic BPs were higher
in non-dippers than in dippers. The other parameters were
similar between the two groups.
Endothelial function in dippers and nondippers. The
intra-arterial infusion of ACh increased FBF in a dose-
dependent manner in both groups. The response of FBF to
ACh was smaller in non-dipper patients than in dipper
patients (p  0.001; Fig. 1, top panel). The intra-arterial
infusion of ISDN also increased FBF in a dose-dependent
manner in both groups. The FBF response to ISDN was
similar in dippers and non-dippers (Fig. 1, bottom panel).
No change in the arterial BP or heart rate occurred with the
intra-arterial infusion of either ACh or ISDN in either
group.
The 24-h urinary excretions of NOx and cGMP were
lower in nondipper patients than in dipper patients (Fig. 2).
Effects of L-NMMA on the forearm vascular response to
ACh infusion. The intra-arterial infusion of the NO
synthase inhibitor L-NMMA decreased basal FBF in both
groups. Changes in the basal forearm vascular responses to
L-NMMA infusion were similar in the two groups. The
L-NMMA infusion also decreased the FBF response to
ACh infusion in both groups. There was no significant
difference in the change in the FBF response to ACh after
L-NMMA infusion between the two groups (Fig. 3). No
change in arterial BP or heart rate occurred during the
infusion of L-NMMA in either group.
Table 1. Clinical Characteristics of Dipper and Non-Dipper
Patients
Parameter
Dipper
(n  20)
Non-Dipper
(n  20)
Body mass index (kg/m2) 23.1  2.3 23.2  2.1
Heart rate (beats/min) 62.5  8.9 61.0  9.3
Total cholesterol (mmol/l) 4.4  0.2 4.3  0.2
Serum glucose (mmol/l) 5.0  0.1 4.9  0.1
Plasma renin activity
(ng AngI/ml/h)
0.81  0.36 1.19  0.22
Plasma angiotensin II (pg/ml) 17.4  9.8 18.6  9.1
Plasma norepinephrine (nmol/l) 1.01  0.25 1.06  0.28
Urinary norepinephrine (g/d) 83  25 96  31
Urinary sodium (mmol/d) 163  39 165  42
24-h ABPM
24-h SBP (mm Hg) 133.9  12.1* 148.4  12.5
24-h DBP (mm Hg) 87.6  8.4 91.6  8.6
Daytime SBP (mm Hg) 145.6  11.9 149.7  12.1
Daytime DBP (mm Hg) 91.6  7.8 92.7  8.7
Nighttime SBP (mm Hg) 127.2  10.3* 144.8  12.3
Nighttime DBP (mm Hg) 75.4  8.2* 89.3  8.3
FBF (ml/min/100 ml tissue) 4.4  1.1 4.3  1.0
Smoker (number of subjects) 6 5
All results are presented as mean  SD. *p  0.05 versus nondipper.
ABPM ambulatory blood pressure monitoring; DBP diastolic blood pressure;
FBF  forearm blood flow; SBP  systolic blood pressure.
Figure 1. Line graphs show the forearm blood flow (FBF) response to
intra-arterial acetylcholine (top panel) and isosorbide dinitrate (bottom
panel) infusion in patients with dipper and non-dipper essential hyperten-
sion.
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DISCUSSION
The forearm vascular response to ACh, but not ISDN,
infusion is impaired in non-dippers, indicating that
endothelium-dependent vasodilation of the brachial artery
is selectively impaired in non-dipper hypertension. Intra-
arterial infusion of the NO synthase inhibitor L-NMMA
abolished the greater FBF response to ACh in dippers. In
addition, the 24-h urinary excretion of NOx and cGMP,
indices of NO production, was less in non-dippers than in
dippers. These findings suggest that endothelium-
dependent vasodilation induced by ACh, ACh-stimulated
NO production, and daily NO production are blunted in
non-dipper hypertension.
Endothelial function becomes progressively more im-
paired as BP increases (12,13). In the present study, the
nocturnal BP was higher in non-dippers than in dippers,
whereas the daytime BP was similar in the two groups.
Although BP was similar in dippers and nondippers during
measurement of the FBF response (8:30 AM to 12:00 PM), an
inappropriate reduction in nocturnal BP may contribute to
impaired endothelium-dependent vasodilation in non-
dippers.
Although the precise mechanisms by which shear stress
stimulates NO release from vascular endothelial cells are not
fully known, the endothelium is sensitive to shear stress and
can respond to changes in shear stress associated with small
increases in fluid viscosity (14). Recently, Lip et al. (15)
demonstrated that plasma viscosity correlates both with the
mean daytime and mean nocturnal systolic BPs, suggesting
that changes in BP may affect the plasma viscosity. There-
fore, the diminished nocturnal decline in BP in non-dippers
seen in the present study may be linked to increased
nocturnal plasma viscosity, resulting in deceased shear stress
and NO production.
A potent vasoconstrictor, NE attenuates endothelium-
dependent vasodilation (16). Previous studies have shown
that abnormalities in autonomic function, especially in the
sympathetic nervous activity, inhibit the nocturnal decline
in BP (17,18). However, both plasma and urinary NE
concentrations were similar in dippers and nondippers.
Therefore, it is unlikely that differences in the FBF response
to ACh between dippers and non-dippers can be explained
by differences in sympathetic activity.
Clinical implications. Perticone et al.(19) reported that
when patients with essential hypertension were divided into
three groups based on the magnitude of the FBF response to
ACh infusion, the lower response group (poor endothelial
function) had a higher prevalence of cardiovascular events
during a mean follow-up of 31.5 months (range 4 to 84
months). Several investigators have demonstrated that an
abnormal decline in nocturnal BP affects the prognosis for
cardiovascular disease or stroke in hypertensive patients
(9,10). Endothelial dysfunction, in addition to initiating
atherosclerosis, contributes to its progression. Thus, it is
likely that impaired endothelial function contributes to the
Figure 2. Bar graphs show the 24-h urinary excretion of nitrite/nitrate (NOx) and cGMP in patients with dipper and non-dipper essential hyperten-
sion.
Figure 3. Line graphs show the forearm blood flow (FBF) response to
intra-arterial acetylcholine infusion in the presence of the nitric oxide
synthase inhibitor NG-monomethyl-L-arginine (L-NMMA) in patients
with dipper and non-dipper essential hypertension.
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higher prevalence of cardiovascular and cerebrovascular
complications in non-dippers. Hypertensive patients also
have endothelial dysfunction compared to normotensive
subjects (1–6) and a worse prognosis (8–11). Treatment of
hypertension has been associated with an improvement in
outcome. The non-dippers probably represent a worse
course of hypertension with more endothelial dysfunction.
The aim of antihypertensive therapy is ultimately to prevent
cardiovascular and cerebraovascular complications and renal
dysfunction. Therefore, it is clinically important to individ-
ualize treatment, including both pharmacologic and non-
pharmacologic therapy, to improve endothelial function and
restore a normal circadian pattern of BP in patients with
essential hypertension. Treatment of non-dippers to render
them dippers could partially normalize their endothelial
function and partially improve their prognosis.
We wish to emphasize that sodium intake should be
regulated when assessing diurnal BP variation, because
changes in sodium intake affect the nocturnal BP in hyper-
tensive patients, particularly salt-sensitive hypertensive pa-
tients. In the present study, we maintained a constant
sodium intake (170 mmol/day) for one week before data
collection. We previously confirmed that this amount of
sodium does not affect BP, even in patients with salt-
sensitive essential hypertension (20).
Study limitations. In the present study, endothelium-
dependent vasodilation induced by intra-arterial ACh infu-
sion was impaired even during the day in non-dippers.
Measuring the FBF response to ACh when the BP is lowest
(2:00 AM to 4:00 AM) may permit more specific conclusions
to be drawn about the relationship between endothelial
function and the circadian rhythm of BP. However, the
ACh infusion study cannot be performed when patients are
sleeping.
In conclusion, endothelium-dependent vasodilation in-
duced by ACh is impaired in non-dippers to a greater extent
than dippers. Additionally, NO production per se is reduced
in non-dippers.
Acknowledgment
The investigators thank Yuko Omura for her secretarial
assistance.
Reprint requests and correspondence: Dr. Yukihito Higashi,
Department of Cardiovascular Physiology and Medicine, Gradu-
ate School of Biomedical Sciences, Hiroshima University, 1-2-3
Kasumi, Minami-ku, Hiroshima 734-8551, Japan. E-mail:
yhigashi@hiroshima-u.ac.jp.
REFERENCES
1. Taddei S, Virdis A, Ghiadoni L, et al. Vitamin C improves
endothelium-dependent vasodilation by restoring nitric oxide activity
in essential hypertension. Circulation 1998;97:2222–9.
2. Panza JA, Quyyumi AA, Brush JE, Jr, et al. Abnormal endothelium-
dependent vascular relaxation in patients with essential hypertension.
N Engl J Med 1990;323:22–7.
3. Higashi Y, Sasaki S, Kurisu S, et al. Regular aerobic exercise augments
endothelium-dependent vascular relaxation in normotensive as well as
hypertensive subjects—role of endothelium-derived nitric oxide. Cir-
culation 1999;100:1194–202.
4. Treasure CB, Klein JL, Vita JA, et al. Hypertension and left ventric-
ular hypertrophy are associated with impaired endothelium-mediated
relaxation in human coronary resistance vessels. Circulation 1993;87:
86–93.
5. Higashi Y, Oshima T, Ozono R, et al. Effects of L-arginine infusion
on renal hemodynamics in patients with mild essential hypertension.
Hypertension 1995;25:898–902.
6. Schiffrin EL, Deng LY. Comparison of effects of angiotensin
I-converting enzyme inhibition and -blockade for 2 years on function
of small arteries from hypertensive patients. Hypertension 1995;25:
699–703.
7. Pickering TG, for an American Society of Hypertension Ad Hoc
Panel. Recommendations for the use of home (self) and ambulatory
blood pressure monitoring. Am J Hypertens 1995;9:1–11.
8. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk
using conventional vs ambulatory blood pressure in older patients with
systolic hypertension: Systolic Hypertension in Europe Trial Investi-
gators. JAMA 1999;282:539–46.
9. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood
pressure: an independent predictor of prognosis in essential hyperten-
sion. Hypertension 1994;24:793–801.
10. Kario K, Pickering TG, Matsuo T, et al. Stroke prognosis and
abnormal nocturnal blood pressure falls in older hypertensives. Hyper-
tension 2001;38:852–7.
11. White WB, Pickering TG, Morganroth J, et al. A multicenter
evaluation of the A&D TM-2420 ambulatory blood pressure recorder.
Am J Hypertens 1991;4:890–6.
12. Dohi Y, Thiel MA, Buhler FR, et al. Activation of endothelial
L-arginine pathway in resistance arteries. Effect of age and hyperten-
sion. Hypertension 1990;16:170–9.
13. Panza JA, Casino PR, Kilcoyne CM, et al. Role of endothelium-
derived nitric oxide in the abnormal endothelium-dependent vascular
relaxation of patients with essential hypertension. Circulation 1993;
87:1468–74.
14. Pinsky DJ, Patton S, Mesaros S, et al. Mechanical transduction of
nitric oxide synthesis in the beating heart. Circ Res 1997;81:372–9.
15. Lip GY, Blann AD, Farooqi IS, et al. Abnormal haemorheology,
endothelial function and thrombogenesis in relation to hypertension in
acute (ictus 12 h) stroke patients: the West Birmingham Stroke
Project. Blood Coagul Fibrinolysis 2001;12:307–15.
16. Ohyanagi M, Nishigaki K, Faber JE. Interaction between microvas-
cular alpha 1-and alpha 2-adrenoceptors and endothelium-derived
relaxing factor. Circ Res 1992;71:188–200.
17. Littler WA, Watson RD, Stallard TJ. Circadian variation of blood
pressurey. Lancet 1978;i:995–6.
18. Watson RD, Hamilton CA, Reid JL, et al. Changes in plasma
norepinephrine, blood pressure, and heart rate during physical acticity
in hypertensive man. Hypertension 1979;1:341–6.
19. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of
endothelial dysfunction in hypertensive patients. Circulation 2001;
104:191–6.
20. Higashi Y, Oshima T, Ozono R, et al. Nocturnal decline in blood
pressure is attenuated by NaCl loading in salt-sensitive patients with
essential hypertension: noninvasive 24-hour ambulatory blood pressure
monitoring. Hypertension 1997;30:163–7.
2043JACC Vol. 40, No. 11, 2002 Higashi et al.
December 4, 2002:2039–43 Circadian BP and Endothelial Function
